Prime Medicine, Inc Common Stock
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $1,115 | $1,454 | $2,183 | $209 |
Gross Profit | -749 | 1,454 | 2,183 | 209 |
EBITDA | -53,377 | -50,692 | -42,505 | -52,674 |
EBIT | -55,241 | -52,392 | -44,222 | -54,232 |
Net Income | -52,591 | -51,890 | -42,276 | -52,518 |
Net Change In Cash | 1,115 | 1,454 | 2,183 | 209 |
Free Cash Flow | -42,984 | -51,279 | 14,454 | -27,189 |
Cash | 53,804 | 91,877 | 182,476 | 117,977 |
Basic Shares | 129,186 | 130,884 | 118,600 | 119,764 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $2,983 | $0 | $5,210 | $0 |
Gross Profit | 2,983 | -4,653 | -12,014 | -4,861 |
EBITDA | -196,339 | -193,759 | -110,755 | -160,992 |
EBIT | -202,467 | -198,412 | -122,769 | -165,853 |
Net Income | -195,882 | -198,133 | -121,821 | -165,367 |
Net Change In Cash | 2,983 | 0 | 5,210 | 0 |
Cost of Revenue | 2,571 | |||
Free Cash Flow | -130,159 | -174,136 | -147,922 | -38,232 |
Cash | 182,476 | 41,574 | 187,620 | 185,420 |
Basic Shares | 118,600 | 90,969 | 97,209 | 64,900 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.41 |
2025-03-31 | -$0.40 |
2024-12-31 | -$0.31 |
